Skip to content
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboardSign in
UpLiftRx
MedicationsLabsProvidersVisitsOrdersDashboard
Sign in
Transparency
  • Company
  • Our clinicians
  • Pharmacy partners
  • Where we operate
  • Accreditation
Legal
  • Terms of Service
  • Privacy Policy
  • Notice of Privacy Practices
  • Telehealth Consent
  • Auto-Renewal Terms
  • Refund & Shipping
  • Pharmacy Disclosure
  • Prescribing Policy
  • Patient Rights & Nondiscrimination
  • Texas Medical Board Complaint Notice
  • SMS Terms
  • Cookies
  • California Privacy
  • Accessibility
Support
  • support@upliftrx.co
  • Member sign in

Medical emergency? Call 911. In crisis? Call or text 988 (Suicide & Crisis Lifeline). UpLiftRX is not for emergencies.

Prescription products require an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Available to adults 18+ in states where our clinicians are licensed.

Compounded medications are prepared by state-licensed pharmacies for an individual patient and are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed.

Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX provides a technology platform and is not a pharmacy or a medical provider. Medical services are provided by independent, licensed clinicians of a professional medical group (being finalized). Prescriptions are dispensed by independent, state-licensed pharmacies. Latitude Investments Management Ltd. Liability Co., a Wyoming limited liability company (filing no. 2024-001499647), 5709 Gardendale Dr, STE D, Houston, TX 77092.

Wegovy® and Saxenda® are registered trademarks of Novo Nordisk A/S. Zepbound® and Cialis® are registered trademarks of Eli Lilly and Company. Contrave® is a registered trademark of Currax Pharmaceuticals LLC. Viagra® is a registered trademark of Viatris Specialty LLC. All trademarks are the property of their respective owners. UpLiftRX is not affiliated with or endorsed by any drug manufacturer, and generic medications are not the brand-name products.

© 2026 Latitude Investments Management Ltd. Liability Co. d/b/a UpLiftRX.
  1. Home/
  2. Medications/
  3. Dermatology/
  4. Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide
Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Dermatology

Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide Topical

Topical

Five-ingredient topical acne gel: clindamycin 1%, spironolactone 2%, benzoyl peroxide 5%, niacinamide 2%, and tretinoin 0.025%. Commercial clindamycin/tretinoin gels (Ziana, Veltin) do not include spironolactone, benzoyl peroxide, or niacinamide. Apply at bedtime. Benzoyl peroxide can bleach fabric; tretinoin is light-sensitive.

$90/ month· visit, medication & shipping · charged only if prescribed
Specification
Just this one: start consultation

Add several treatments and check out once. $0 today; each is charged only if prescribed.

Rx only · adults 18+. Requires an online consultation with an independent, licensed clinician, who decides whether treatment is appropriate. Compounded medications are prepared by a state-licensed pharmacy and are not FDA-approved.

Safety: Tretinoin makes your skin sensitive to sunlight. Important safety information

Know before you start

How Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide treatment works

How it works

Prescription skin treatment uses clinically established actives — tretinoin to accelerate cell turnover and stimulate collagen, hydroquinone and azelaic acid for pigment, compounded together at strengths matched to your skin.

What to expect

  • Weeks 1–4: 'retinization' — mild dryness, flaking, or purging is normal.
  • Weeks 6–12: texture, tone, and breakouts visibly improve.
  • Months 3+: collagen-level changes (fine lines, firmness) become apparent.

Common side effects

  • Dryness, redness, and peeling during the first weeks
  • Increased sun sensitivity (daily SPF is required)
  • Temporary purging of breakouts

Safety & who it's not for

Tretinoin and hydroquinone are not used during pregnancy or breastfeeding. Use sunscreen daily. Your clinician will review your routine and adjust strength as your skin adapts.

Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide FAQ

What is Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide?

Five-ingredient topical acne gel: clindamycin 1%, spironolactone 2%, benzoyl peroxide 5%, niacinamide 2%, and tretinoin 0.025%. Commercial clindamycin/tretinoin gels (Ziana, Veltin) do not include spironolactone, benzoyl peroxide, or niacinamide. Apply at bedtime. Benzoyl peroxide can bleach fabric; tretinoin is light-sensitive. It is compounded for you by a state-licensed 503A pharmacy and is not FDA-approved.

How much does Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide cost?

Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide starts at $90 per month through UpLiftRX. The price includes the online clinician visit, the medication, and shipping. Your card is charged only if a licensed clinician prescribes it.

How is Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide taken?

Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide is taken applied to the skin. Typical pharmacy directions read: "Apply 0.25 mL (tretinoin 62.5 mcg / benzoyl peroxide 12.5 mg / clindamycin 2.5 mg / niacinamide 5 mg / spironolactone 5 mg) to the face at bedtime." Your clinician sets your actual dose and schedule, and the pharmacy label on your prescription is what you follow.

Is Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide FDA-approved?

No. Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide is a compounded preparation, and compounded drugs are not FDA-approved. FDA has approved other products that contain clindamycin (for example Cabtreo, Cleocin, Clindacin Etz); a compounded version is prepared for an individual patient when a clinician decides it is appropriate.

Do I need a prescription for Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide?

Yes. Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide requires a prescription. Start an online visit, answer the health questionnaire, and a licensed clinician reviews it. If Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide is appropriate, the clinician prescribes it and a licensed pharmacy ships it to you.

How should I store Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide?

Store at room temperature, away from heat and moisture.

Where does Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide ship?

Pharmacies in our network can ship Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide to 49 states and DC (not California). It is not currently available in 1 state; the online visit checks your state first. Orders typically arrive in 2 days after the pharmacy ships, and shipping is included in the price.

What does the research say about Clindamycin?

PubMed indexes 14,405 publications that mention Clindamycin, including 959 randomized trials, systematic reviews, or meta-analyses. ClinicalTrials.gov lists 339 registered studies. Study results for FDA-approved products do not transfer automatically to compounded preparations. The sources are linked on this page.

Can I use it with my current skincare?

Usually yes, with sequencing guidance — but avoid layering other strong actives (AHAs, benzoyl peroxide) at the same time of day. Your clinician will map your routine.

When do I apply it?

At night, on dry skin, a pea-sized amount for the whole face. Less is more — using extra increases irritation, not results.

Important safety information

Photosensitivity and pregnancy

Tretinoin makes your skin sensitive to sunlight. Daily broad-spectrum SPF 30+ is required while you use it. Do not use during pregnancy or while trying to conceive — discuss timing with your clinician.

Compounded drugs are not FDA-approved; FDA does not review them for safety, effectiveness, or quality before they are dispensed. Tell your clinician about all medications and supplements you take. Seek emergency care (call 911) for severe reactions. Report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Similar products

Similar to Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide

See all in Dermatology →
Doxycycline Hyclate oral, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Dermatology
Doxycycline Hyclate
3 options
Adapalene + Benzoyl peroxide topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Dermatology
Adapalene + Benzoyl peroxide
0.1% / 2.5%
Latanoprost solution, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Dermatology
Latanoprost
0.05 mg/mL
Hydroquinone + Tretinoin + Hydrocortisone topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Dermatology
Hydroquinone + Tretinoin + Hydrocortisone
6% / 0.025% / 1%
Sulfacetamide sodium topical, compounded prescription medication, UpLiftRX packagingCompounded · Not FDA-approved
Dermatology
Sulfacetamide sodium
10%
$90/mo
On this pageOverviewStrengths & pricesHow it's takenStorage & shippingResearch & sourcesFAQReviewsSafety
At a glance

What is Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide Topical?

Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide is a compounded topical preparation prepared for an individual patient by a state-licensed 503A compounding pharmacy. It is not FDA-approved. Route: applied to the skin. Through UpLiftRX it costs from $90 per month, including the online visit, the medication, and shipping. You are charged only if a licensed clinician prescribes it. It can ship to 49 states and DC (not California).

Form
Topical
Route
Applied to the skin
Active ingredients
Clindamycin, Tretinoin, Spironolactone, Benzoyl peroxide, Niacinamide
Options
1 strength and size option
Price
$90 per month, visit and shipping included
Prescription
Required. A licensed clinician decides whether it is appropriate.
FDA status
Compounded. Not FDA-approved; FDA does not review compounded drugs before they are dispensed.
Dispensed by
A state-licensed 503A compounding pharmacy
Ships to
49 states and DC (not California)
Storage
Store at room temperature, away from heat and moisture.
Availability
In stock at one or more pharmacies

Product details from our pharmacy network's catalog, updated October 22, 2026.

Strengths & prices

Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide Topical strengths and prices

1 option. Prices are per month and include the online visit, the medication, and shipping; you are charged only if a clinician prescribes it.
StrengthSizePriceAvailability
1% / 2% / 5% / 2% / 0.025%30 mL gel$90In stock
How it's taken

How to take Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide Topical

Route and directions

Route: Applied to the skin

Example pharmacy label: “Apply 0.25 mL (tretinoin 62.5 mcg / benzoyl peroxide 12.5 mg / clindamycin 2.5 mg / niacinamide 5 mg / spironolactone 5 mg) to the face at bedtime.”

Your clinician sets your dose and schedule. Follow the label on your own prescription, not this example.

Preparation and supplies

Mixing: None. It ships ready to use.

Storage & shipping

Storing and shipping Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide Topical

Storage

Store at room temperature, away from heat and moisture.

Keep out of reach of children. Do not use after the beyond-use date on the label.

Shipping

Ships to 49 states and DC (not California), typically arriving in 2 days after the pharmacy ships. Shipping is included in the price.

States it ships to

Alaska, Alabama, Arkansas, Arizona, Colorado, Connecticut, District of Columbia, Delaware, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia, Wyoming

Clinical research & sources

Research on the ingredients in Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide Topical

Published research and public drug references for each active ingredient, from the U.S. National Library of Medicine (PubMed, MedlinePlus, DailyMed, RxNorm, PubChem), ClinicalTrials.gov, and FDA. These studies are about the ingredients, often in FDA-approved products. None of them tested this compounded preparation, and their results do not automatically apply to it.

Clindamycin

FDA status: FDA has approved products that contain clindamycin, including Cabtreo, Cleocin, Clindacin Etz.

PubMed: 14,405 publications mention Clindamycin, 959 of them trials or reviews. Search PubMed

  1. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Liu H et al. The Cochrane database of systematic reviews, 2020. Meta-Analysis, Systematic Review. PMID 32356369 · DOI
  2. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Mavranezouli I et al. The British journal of dermatology, 2022. Systematic Review, Network Meta-Analysis. PMID 35789996 · DOI
  3. Antibiotic regimens for postpartum endometritis. Mackeen AD et al. The Cochrane database of systematic reviews, 2015. Meta-Analysis, Systematic Review. PMID 25922861 · DOI
  4. Antibiotic prophylaxis in the prevention of dry socket and surgical site infection after lower third molar extraction: a network meta-analysis. Camps-Font O et al. International journal of oral and maxillofacial surgery, 2024. Network Meta-Analysis, Systematic Review. PMID 37612199 · DOI
  5. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis. Parks T et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. Meta-Analysis, Systematic Review. PMID 29788397 · DOI

ClinicalTrials.gov: 339 registered studies. See all studies

  • NCT01378832 Effect of Peritoneal Lavage With Clindamycin-gentamicin Solution on Postoperative Colorectal Cancer Infection in Elective Surgery (Phase 3), completed
  • NCT01047189 Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris (Phase 4), completed

MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 2582 ↗PubChem CID 446598 ↗Wikipedia ↗

Tretinoin

FDA status: FDA has approved products that contain tretinoin, including Renova, Retin-A, Tri-Luma, Twyneo.

ClinicalTrials.gov: 406 registered studies. See all studies

  • NCT00647556 Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage (Phase 3), completed

MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 10753 ↗PubChem CID 444795 ↗Wikipedia ↗

Spironolactone

FDA status: FDA has approved products that contain spironolactone, including Aldactone, Carospir.

PubMed: 7,870 publications mention Spironolactone, 843 of them trials or reviews. Search PubMed

  1. Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial. Lee CJ et al. JAMA, 2025. Clinical Trial, Phase IV. PMID 40366680 · DOI
  2. Spironolactone for heart failure with preserved ejection fraction. Pitt B et al. The New England journal of medicine, 2014. Randomized Controlled Trial. PMID 24716680 · DOI
  3. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Williams B et al. Lancet (London, England), 2015. Randomized Controlled Trial. PMID 26414968 · DOI
  4. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. Pitt B et al. The New England journal of medicine, 1999. Clinical Trial, Randomized Controlled Trial. PMID 10471456

Benzoyl peroxide

FDA status: FDA has approved products that contain benzoyl peroxide, including Acanya, Benzamycin, Cabtreo.

PubMed: 1,994 publications mention Benzoyl peroxide, 287 of them trials or reviews. Search PubMed

  1. Guidelines of care for the management of acne vulgaris. Reynolds RV et al. Journal of the American Academy of Dermatology, 2024. Systematic Review. PMID 38300170 · DOI
  2. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Liu H et al. The Cochrane database of systematic reviews, 2020. Meta-Analysis, Systematic Review. PMID 32356369 · DOI
  3. Acne and the cutaneous microbiome: A systematic review of mechanisms and implications for treatments. Podwojniak A et al. Journal of the European Academy of Dermatology and Venereology : JEADV, 2025. Systematic Review. PMID 39269130 · DOI
  4. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Mavranezouli I et al. The British journal of dermatology, 2022. Systematic Review, Network Meta-Analysis.

Niacinamide

FDA status: FDA has approved products that contain niacinamide, including Infuvite Pediatric.

PubMed: 958 publications mention Niacinamide, 86 of them trials or reviews. Search PubMed

  1. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Hakozaki T et al. The British journal of dermatology, 2002. Clinical Trial, Randomized Controlled Trial. PMID 12100180 · DOI
  2. Niacinamide: A B vitamin that improves aging facial skin appearance. Bissett DL et al. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005. Clinical Trial, Randomized Controlled Trial. PMID 16029679 · DOI
  3. Topical treatment for postinflammatory hyperpigmentation: a systematic review. Tan MG et al. The Journal of dermatological treatment, 2022. Systematic Review. PMID 34525885 · DOI
  4. The effect of 2% niacinamide on facial sebum production. Draelos ZD et al. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2006. Clinical Trial, Randomized Controlled Trial.

Sources checked October 22, 2026. Listing a study is not a claim that this product is safe or effective for you; a licensed clinician makes that decision.

Patient reviews

Reviews come only from patients who received Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide Topical through UpLiftRX. Each is checked for privacy and safety before it's published; we never remove a review for being negative. Individual experiences vary, and reviews aren't medical advice.

No reviews yet. Patients who receive Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide Topical through UpLiftRX can leave a review after delivery.

For patients who received Clindamycin + Tretinoin + Spironolactone + Benzoyl peroxide + Niacinamide Topical.
· DOI
  • Comparative effectiveness and safety of eplerenone and spironolactone in patients with heart failure: a systematic review and meta-analysis. Elshahat A et al. BMC cardiovascular disorders, 2024. Systematic Review, Meta-Analysis. PMID 39271992 · DOI
  • ClinicalTrials.gov: 329 registered studies. See all studies

    MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 9997 ↗PubChem CID 5833 ↗Wikipedia ↗

    PMID 35789996
    · DOI
  • Topical Retinoids in Acne Vulgaris: A Systematic Review. Kolli SS et al. American journal of clinical dermatology, 2019. Systematic Review. PMID 30674002 · DOI
  • ClinicalTrials.gov: 229 registered studies. See all studies

    MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 1418 ↗PubChem CID 7187 ↗Wikipedia ↗

    PMID 16766489
    · DOI
  • Axillary Hyperpigmentation Treatment: A Systematic Review of the Literature. Vahabi SM et al. Journal of cosmetic dermatology, 2025. Systematic Review. PMID 40843925 · DOI
  • ClinicalTrials.gov: 1,466 registered studies. See all studies

    MedlinePlus drug information ↗RxNorm 7405 ↗PubChem CID 936 ↗Wikipedia ↗